Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

F9 Gene Hemophilia B Next‑Generation Sequencing (NGS) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين F9 للكشف عن الهيموفيليا B عبر التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Laboratories (Cert: INT/EGQ/2509DA/3139).
  • Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM daily).
  • Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation with a DHA‑licensed genetic counsellor.
  • Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
  • ملخص تنفيذي: دقة تشخيص 99.9% عبر معالجة مخبرية معتمدة ISO، واستشارة وراثية بعد الاختبار، وخدمة سحب منزلي متميزة.

UAE Regulatory Compliance

This genetic test fully complies with Federal Decree‑Law No. 41 of 2024 (Article 87) on the protection of genetic data, the UAE Personal Data Protection Law (PDPL), and the 2026 Communicable Diseases & Genetic Screening Law (CDS Law) requiring informed parental consent for minors. All processing is performed in an ISO 9001:2015 accredited facility.

Overview

The F9 Gene Hemophilia B Genetic Test uses Next‑Generation Sequencing to analyse the entire F9 gene for pathogenic variants that cause factor IX deficiency (hemophilia B). Ideal for diagnostic confirmation, carrier screening, and prenatal planning, this test delivers 99.9% sensitivity and is processed in an ISO‑certified Dubai laboratory.

يُستخدم اختبار جين F9 بتقنية التسلسل الجيني المتقدم لتأكيد تشخيص الهيموفيليا B وكشف الحاملين للطفرة، مع دقة 99.9% في مختبر معتمد ISO.

Feature Our Test (DHA‑Certified) Closest Alternative
Methodology Next‑Generation Sequencing (NGS) – full gene coverage Sanger sequencing (selected exons only)
Turnaround Time 3 – 4 weeks 4 – 6 weeks
Diagnostic Sensitivity 99.9% (deep intronic variants included) ~85%
Pre‑ & Post‑Test Genetic Counselling Included (DHA‑licensed counsellors) Often not included

Physician Insight & Safety Protocol

“As a DHA‑licensed hematopathologist, I always remind families that a genetic test is one piece of the puzzle – it must be correlated with clinical bleeding history, factor IX activity levels, and family pedigree. Please do not discontinue any prescribed clotting factor therapies or medications without direct consultation with your treating physician.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011

Medication Warning

Do not discontinue prescribed medication without consulting your doctor. Stopping factor IX concentrates or other haemostatic agents abruptly may provoke life‑threatening bleeding. This genetic test assesses your DNA; it does not replace emergency treatment plans.

Patient Safety & Exclusion Criteria

  • Sample contamination: Whole blood, extracted DNA, or FTA card must be collected aseptically; clotted or hemolysed samples will be rejected.
  • Incomplete clinical history: A full pedigree chart and bleeding questionnaire must be submitted; missing data delays reporting.
  • Pregnancy‑related counselling: If undergoing prenatal diagnosis, an invasive procedure (amniocentesis/CVS) must be performed by a qualified obstetrician.
  • ER Red Flags: If you experience sudden severe joint pain, prolonged bleeding after injury, haematuria, or intracranial pressure signs (headache, visual changes, vomiting), go to your nearest emergency department immediately regardless of test status.

Patient FAQ & Clinical Guidance

1. What is the F9 Gene Hemophilia B NGS test, and who should consider it?

Snippet: The F9 gene hemophilia B NGS test is a comprehensive DNA analysis that screens the entire F9 gene for mutations causing factor IX deficiency. It is recommended for individuals with a personal or family history of prolonged bleeding, unexplained hematomas, or low factor IX activity, and for carrier detection in female relatives.

ما هو اختبار جين F9 للهيموفيليا B بتقنية NGS، ومن ينبغي له إجراؤه؟ – اختبار شامل للحمض النووي يحلل جين F9 بالكامل للكشف عن الطفرات المسببة لنقص العامل التاسع. يُوصى به للأشخاص الذين لديهم تاريخ نزيف غير مفسر أو انخفاض نشاط العامل التاسع، وللكشف عن الحاملات من الأقارب الإناث.

2. How should I prepare for the, and what sample is required?

Snippet: Preparation requires a genetic counselling session to draw a detailed family pedigree and provide a blood sample—whole blood, extracted DNA, or a single drop on an FTA card. No fasting is needed, and you should continue all prescribed medications; only your doctor may adjust therapy.

كيف أستعد للاختبار وما هي العينة المطلوبة؟ – تحتاج إلى جلسة استشارة وراثية لرسم شجرة العائلة وتقديم عينة دم (دم كامل، حمض نووي مستخلص، أو قطرة دم على بطاقة FTA). لا يشترط الصيام، ويجب الاستمرار على الأدوية الموصوفة ما لم يوجه الطبيب بغير ذلك.

3. Are my genetic data and privacy protected under UAE law?

Snippet: Your genetic data is strictly protected under Federal Decree‑Law No. 41 of 2024 and the UAE Personal Data Protection Law, with processing limited to diagnosis and counselling. Results are shared only with you and your referring physician, never with employers, insurers, or third parties without explicit consent.

هل بياناتي الجينية محمية بموجب القانون الإماراتي؟ – بياناتك الجينية محمية بصرامة بموجب المرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية، وتقتصر معالجتها على التشخيص والاستشارة. لا تُشارك النتائج مع جهات التأمين أو العمل دون موافقة صريحة.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians